The Surgical AI Supercycle: A Generational Allocation Shift
How artificial intelligence is transforming surgical outcomes from specialised skill to industrial standard — and what this means for institutional capital allocation.
Read Article
Sigma Capital backs the technologies and platforms redefining surgical care — where AI, robotics, and data converge to improve outcomes at global scale.
Founded by Bjoern von Siemens, Sigma Capital builds on a 175-year family legacy in industrial engineering and healthcare technology to shape the next frontier of AI-native surgery.
Sigma invests selectively across the surgical AI value chain, focusing on the infrastructure layers where long-term strategic advantage is created — including data capture, workflow integration, connectivity systems, and enabling robotics platforms.
As an evergreen investment platform, Sigma deploys capital flexibly across platform formation, growth-stage scaling, and strategic acquisition opportunities. Rather than operating within fixed fund cycles, Sigma takes ownership positions ranging from strategic minority stakes to control and co-control investments where infrastructure ownership is critical.
Backed by a European industrial family with global reach across software, automation, energy, and healthcare, Sigma Capital combines strong ties to leading academic institutions with access to key EU and US healthcare stakeholders. Beyond capital, Sigma brings clinical networks, regulatory expertise, operational know-how, leadership talent, and medtech distribution access.
With offices in Abu Dhabi, Berlin, Chicago, London, and San Francisco, Sigma unites Europe's industrial and clinical strength, US innovation and capital markets, Middle Eastern long-term capital, and Asia's manufacturing scale in one integrated global platform.
Sigma brings over 15 years of surgical and AI investing and operating experience, with over $300 million deployed across the ecosystem, including early positions in Intuitive Surgical and Auris Health, and the founding platform behind Caresyntax.
From early-stage platforms to global category leaders, Sigma's portfolio reflects over a decade of focused conviction in surgical and health data infrastructure.














Includes direct investments and fund investments made through Sigma Capital and surgical.ai vehicles.
How artificial intelligence is transforming surgical outcomes from specialised skill to industrial standard — and what this means for institutional capital allocation.
Read Article
Sigma's ecosystem spans leading healthcare providers, medtech companies, and institutional partners — united by a shared commitment to advancing surgical innovation, patient safety, and long-term value in healthcare — extending into governance, research, and philanthropic initiatives that shape the future of surgical care.




















Advancing AI safety, governance, and ethical frameworks in surgical intelligence.
Sigma contributes to WSS to support breakthrough research addressing critical challenges—from quantum computing and sustainable energy to advanced medical technologies.
Research, philanthropy, and long-term initiatives across healthcare and society.
Sigma's legacy surgical AI investment platform, representing a foundational part of the firm's long-term portfolio and track record in the sector.